Risk factors: Diabetes and cardiovascular risk: Insights from clinical trials

被引：0

|

作者：

Osório J.

机构：

来源：

Nature Reviews Cardiology | 2010年 / 7卷 / 5期

关键词：

D O I：

10.1038/nrcardio.2010.38

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

收藏

页码：239 / 239

相关论文

共 50 条

[41] DiRECT and indirect paths to reducing cardiovascular risk in diabetes: insights from Diabetes UK 2019
Krentz, Andrew, I
CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2019, 8 (02): : 67 - 68
[42] Revisiting clinical trials on glycemic control and cardiovascular risk
Sandra Roberta Gouvea Ferreira
Diabetology & Metabolic Syndrome, 1
[43] USING NOVEL RISK FACTORS IN CLINICAL TRIALS
Ridker, P.
ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
[44] Revisiting clinical trials on glycemic control and cardiovascular risk
Gouvea Ferreira, Sandra Roberta
DIABETOLOGY & METABOLIC SYNDROME, 2009, 1
[45] Outcomes trials indicate no cardiovascular risk for diabetes drug class
Nature Reviews Drug Discovery, 2013, 12 : 728 - 728
[46] Trials of cardiovascular risk factor management in type 2 diabetes
Patel, Anushka
Joshi, Rohina
de Galan, Bastiaan
CURRENT OPINION IN CARDIOLOGY, 2009, 24 (04) : 288 - 294
[47] Outcomes trials indicate no cardiovascular risk for diabetes drug class
不详
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (10) : 728 - 728
[48] Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?
Leigh Perreault
Kristine Færch
Edward W. Gregg
Current Diabetes Reports, 2017, 17
[49] Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?
Perreault, Leigh
Frch, Kristine
Gregg, Edward W.
CURRENT DIABETES REPORTS, 2017, 17 (09)
[50] CRP, Risk Factors and Major Adverse Cardiovascular Events: Insights From ACCELERATE
Scherer, Daniel J.
Nicholls, Stephen J.
Lincoff, A. Michael
Menon, Venu
Riesmeyer, Jeffrey S.
Ruotolo, Giacomo
Weerakkody, Govinda J.
Wolski, Kathy
McErlean, Ellen
Nissen, Steven E.
CIRCULATION, 2017, 136

← 1 2 3 4 5 →